Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Placebo-Controlled Trial of Acyclovir Prophylaxis Versus Placebo Among HIV-1/HSV-2 Co-Infected Individuals in Uganda
Conditions
Interventions
Acyclovir
Placebo
Locations
1
Uganda
Rakai Health Sciences Program, Uganda Virus Research Institute
Kalisizo, Rakai District, Uganda
Start Date
November 1, 2006
Primary Completion Date
October 1, 2010
Completion Date
November 1, 2010
Last Updated
September 28, 2012
NCT06627764
NCT04142047
NCT06694805
NCT05398185
NCT07428330
NCT07225530
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions